CARIPRAZINE CAPS 1.5MG

This tender, originating from Jordan, pertains to the procurement of CARIPRAZINE CAPSULES at a dosage of 1.5mg. The contracting authority is seeking to acquire a specific pharmaceutical product used in the treatment of certain mental health conditions. This procurement is vital for ensuring the availability of essential medications for patients under the care of the contracting health authority. Bidders are expected to be licensed pharmaceutical suppliers capable of providing genuine, high-quality Cariprazine 1.5mg capsules. Key requirements will include adherence to strict pharmaceutical manufacturing and quality control standards (e.g., GMP), proper packaging and labeling compliant with Jordanian regulations, and the ability to demonstrate product authenticity and regulatory approval. The tender may also specify quantities, delivery schedules, and storage requirements. Pharmaceutical companies and authorized distributors with a proven track record in supplying medications, particularly psychiatric drugs, and who can meet the stringent regulatory and quality demands of the Jordanian health sector are invited to bid.